Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

ABN100 Anti-Vesicular Acetylcholine Transporter (VAChT) Antibody

View Products on Sigmaaldrich.com
ABN100
100 µg  
Purchase on Sigma-Aldrich

Special Offers

Overview

Replacement Information

Key Spec Table

Species ReactivityKey ApplicationsHostFormatAntibody Type
R, MIHC, ELISAGtAffinity PurifiedPolyclonal Antibody
Description
Catalogue NumberABN100
DescriptionAnti-Vesicular Acetylcholine Transporter (VAChT) Antibody
Alternate Names
  • Vesicular acetylcholine transporter
  • VAChT
  • rVAT
  • Solute carrier family 18 member 3
Background InformationAcetylcholine mediates cholinergic transmission in the central and peripheral nervous systems, and is an important modulator of cognition, movement, and cardiovascular function, among other processes. The effects of acetylcholine are regulated by its synthesis, storage, and breakdown, which involve the related enzymes choline acetyltransferase (ChAT), vesicular acetylcholine transporter (VAChT), and acetylcholinesterase (AChE), respectively. VAChT is primarily found in the membrane of presynaptic secretory vesicles. It contains 12 transmembrane domains and a synaptic-vesicular–targeting signal located on the intracellular C-terminal tail. The primary function of VAChT is to actively transport cytoplasmic ACh, across an electrochemical gradient, into synaptic vesicles that release ACh upon cell stimulation. The VAChT can affect cholinergic signaling by affecting the relative pools of ACh secreted to activate postsynaptic nicotinic and muscarinic receptors. VAChT is phosphorylated on its serine 480 residue in the C-terminal tail by protein kinase C. Although the precise role of this modification is still unclear, previous studies suggest that it may affect the localization of VAChT to synaptic vesicles.
References
Product Information
FormatAffinity Purified
HS Code3002 15 90
Control
  • Vesicular Acetylcholine Transporter (VAChT) peptide
PresentationPurified goat polyclonal in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Quality LevelMQ100
Applications
ApplicationAnti-Vesicular Acetylcholine Transporter (VAChT) Antibody detects level of Vesicular Acetylcholine Transporter (VAChT) & has been published & validated for use in IHC, ELISA.
Key Applications
  • Immunohistochemistry
  • ELISA
Application NotesImmunohistochemistry Analysis: A 1:1,000 dilution from a representative lot detected Vesicular Acetylcholine Transporter (VAChT) in rat midbrain tissue.
ELISA Analysis: A representative lot detected Vesicular Acetylcholine Transporter (VAChT) in a direct ELISA using a corresponding peptide.
Biological Information
ImmunogenKLH-conjugated linear peptide corresponding to the C-terminus of rat VAChT.
EpitopeC-terminus
ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
HostGoat
SpecificityThis antibody recognizes the C-terminus of Vesicular Acetylcholine Transporter (VAChT).
Species Reactivity
  • Rat
  • Mouse
Species Reactivity NoteDemonstrated to react with Rat and Mouse. Other homologies: Human (95% sequence homology).
Antibody TypePolyclonal Antibody
Entrez Gene Number
Gene Symbol
  • Slc18a3
  • Vacht
  • Vat
Purification MethodAffinity Purfied
UniProt Number
Molecular Weight57 kDa calculated
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceEvaluated by Immunohistochemistry Analysis.
Immunohistochemistry Analysis: A 1:1,000 dilution from a representative lot detected Vesicular Acetylcholine Transporter (VAChT) in mouse midbrain tissue.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
Packaging Information
Material Size100 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
ABN100 04053252696763

Documentation

Anti-Vesicular Acetylcholine Transporter (VAChT) Antibody SDS

Title

Safety Data Sheet (SDS) 

Anti-Vesicular Acetylcholine Transporter (VAChT) Antibody Certificates of Analysis

TitleLot Number
Anti-Vesicular Acetylcholine -2707197 2707197
Anti-Vesicular Acetylcholine -2709035 2709035
Anti-Vesicular Acetylcholine -2778849 2778849
Anti-Vesicular Acetylcholine -2819596 2819596
Anti-Vesicular Acetylcholine Transporter (VAChT) 2465302
Anti-Vesicular Acetylcholine Transporter (VAChT) - 2388359 2388359
Anti-Vesicular Acetylcholine Transporter (VAChT) - 2438664 2438664
Anti-Vesicular Acetylcholine Transporter (VAChT) - 2199694 2199694
Anti-Vesicular Acetylcholine Transporter (VAChT) - 2294373 2294373
Anti-Vesicular Acetylcholine Transporter (VAChT) - 2562015 2562015

References

Reference overviewPub Med ID
Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons.
Pappas, SS; Darr, K; Holley, SM; Cepeda, C; Mabrouk, OS; Wong, JM; LeWitt, TM; Paudel, R; Houlden, H; Kennedy, RT; Levine, MS; Dauer, WT
eLife  4  e08352  2015

Show Abstract
26052670 26052670
Endogenous cholinergic neurotransmission contributes to behavioral sensitization to morphine.
Bajic, D; Soiza-Reilly, M; Spalding, AL; Berde, CB; Commons, KG
PloS one  10  e0117601  2015

Show Abstract
25647082 25647082
Adolescent, but not adult, binge ethanol exposure leads to persistent global reductions of choline acetyltransferase expressing neurons in brain.
Vetreno, RP; Broadwater, M; Liu, W; Spear, LP; Crews, FT
PloS one  9  e113421  2014

Show Abstract
25405505 25405505
A genetically specified connectomics approach applied to long-range feeding regulatory circuits.
Atasoy, D; Betley, JN; Li, WP; Su, HH; Sertel, SM; Scheffer, LK; Simpson, JH; Fetter, RD; Sternson, SM
Nature neuroscience  17  1830-9  2014

Show Abstract
25362474 25362474